Report Raises Questions about Drug's Safety

Concerns have been raised in Canada about the safety of Strattera, a non-stimulant drug intended to treat symptoms of Attention Deficit Hyperactivity Disorder in children. The drug was made available to the public amid praises that it was the first non-stimulant medication that had been effective in the treatment of ADHD.

"New questions are being raised about a drug used to treat attention-deficit hyperactivity disorder amid reports more than 40 Canadian kids have attempted suicide after taking it... Health Canada said it received 189 reports of adverse reactions associated with the non-stimulant drug... Strattera, from the time it was put on the market in February 2005, to the end of last year."

University researchers and doctors are urging parents to educate themselves on possible side effects of all drugs used to treat ADHD, as some health risks are not widely publicized. Source: The London Free Press

Labels: medications, safety